Robert Zeiser

Has grant

Director Div. of Tumor immunology/Professor

University Medical Center Freiburg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

ORCID

Google Scholar

About

Robert Zeiser is a Professor and Director of the Division of Tumor Immunology at the University Medical Center Freiburg, Germany. His research focuses on hematopoietic cell transplantation, particularly in the context of acute leukemias and graft-versus-host disease. Recent contributions include studies on donor selection, TCR-T therapies, and innovative clinical practices in transplant immunology.

Recent Grants

Grant: Close

ERC Consolidator grant

Open Date:

Close Date:

Grant: Close

Immune modulation after allo-HCT

Open Date:

Close Date:

Robert Zeiser

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (30)

Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party

Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms

Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party

Extracorporeal Photopheresis: From Animal Models to Clinical Practice

Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT

Protocol for performing and analyzing a live-cell imaging-based microglia phagocytosis assay using AI on the Olympus ScanR system

Protocol to study phagocytosis of apoptotic murine splenocytes by syngeneic antigen-presenting cells in vitro

Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT

Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study

Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease

Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease

Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell Transplantation

How risky is a second allogeneic stem cell transplantation?

Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial

Introduction to a review series on oncogenic signaling and immune evasion in hematologic malignancies

Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation: From Graft-versus-Host Disease to the Graft-versus-Tumor Effect

Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning

A novel approach to visualize clinical benefit of therapies for chronic graft versus host disease (cGvHD): the probability of being in response (PBR) applied to the REACH3 study

Novel developments in the prophylaxis and treatment of acute GVHD

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia

Chimeric antigen receptor T cells for acute myeloid leukemia

Immune checkpoint inhibitor induced neurocognitive deficits in patients

Pathophysiology of gastrointestinal acute graft‐versus‐host disease and the potential role of glucagon‐like peptide 2

Novel Approaches to the Treatment of Chronic Graft-Versus-Host Disease

The role of the MDM2/p53 axis in anti-tumor immune responses.

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape

Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract

FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation

GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity

Collaborators (11)

Jesus Duque-Afonso

takanori teshima

David Michonneau

Omer Jamy

Emanuele Angelucci

Claudia Wehr

Tilman Brummer

Michael Schmitt

Marco Prinz

Ralph Wäsch

Hildegard Greinix

How do I reach out?

Meet Kite AI